PRACTICE ALERT PODCAST

USPSTF takes another stab at PSA screening recs

Author and Disclosure Information

The latest recommendations from the US Preventive Services Task Force regarding prostate cancer screening have left many health care practitioners in a quandary. That’s especially true since recommendations on the topic have vacillated a great deal over the past 10 years. Dr. Doug Campos-Outcalt summarizes the latest recommendations and provides practical advice on what to tell your patients.


 

Resources

US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:1901-1913.

Carter HB. Prostate-specific antigen (PSA) screening for prostate cancer: revisiting the evidence. JAMA. 2018;319:1866-1868.

US Preventive Services Task Force. Prostate cancer screening final recommendation. Available at: https://screeningforprostatecancer.org/. Accessed May 18, 2018.

US Preventive Services Task Force. Prostate cancer: screening, 2008. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening-2008. Accessed May 15, 2018.

US Preventive Services Task Force. Prostate cancer: screening. May 2012. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screening. Accessed May 15, 2018.

Recommended Reading

Abstract: Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
MDedge Family Medicine
Abstract: Divergent Responses to Mammography and Prostate-Specific Antigen Recommendations
MDedge Family Medicine
Cochrane report: HPV vaccine proves its worth in adolescent, young adult women
MDedge Family Medicine
E-cigarette usage has changed
MDedge Family Medicine
FDA approves epoetin alfa biosimilar to treat anemia
MDedge Family Medicine
Pediatric cancers are on the rise
MDedge Family Medicine
Breath test may detect esophagogastric cancer
MDedge Family Medicine
Uptake of lung cancer screening is exceedingly low
MDedge Family Medicine
Spotlight on nonmelanoma skin cancer’s true burden
MDedge Family Medicine
Psoriasis therapy with biologics not linked to increased cancer risk
MDedge Family Medicine